Tempest Therapeutics (TPST) News Today → The Gold Grab of the Century (From Colonial Metals) (Ad) Free TPST Stock Alerts $3.48 +0.04 (+1.16%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineTempest Therapeutics, Inc. (NASDAQ:TPST) Short Interest Updatemarketbeat.com - April 13 at 1:10 PMTempest Therapeutics (NASDAQ:TPST) Trading Down 6.8%marketbeat.com - April 13 at 12:40 AMBuy Recommendation for Tempest Therapeutics Backed by Promising Cancer Drug Developmentsmarkets.businessinsider.com - April 9 at 5:53 PMTempest Reports New Preclinical Data for TPST-1120 in RCC at the AACR Annual Meetingfinance.yahoo.com - April 9 at 12:51 PMTempest Reports New Preclinical Data for TPST-1120 in RCC at the AACR Annual Meetingglobenewswire.com - April 9 at 8:00 AMTempest Therapeutics moves TPST-1120 into phase 3 trialuk.investing.com - April 6 at 3:43 PMTempest Announces Publication of Positive Data from Phase 1 Trial of TPST-1120 in Patients with Advanced Solid Tumors in Journal of Cancer Research Communicationsfinance.yahoo.com - April 4 at 8:14 AMTempest Announces Publication of Positive Data from Phase 1 Trial of TPST-1120 in Patients with Advanced Solid Tumors in Journal of Cancer Research Communicationsglobenewswire.com - April 4 at 8:00 AMQ3 2024 Earnings Estimate for Tempest Therapeutics, Inc. (NASDAQ:TPST) Issued By HC Wainwrightmarketbeat.com - March 22 at 8:18 AMResearch Analysts Issue Forecasts for Tempest Therapeutics, Inc.'s Q1 2024 Earnings (NASDAQ:TPST)marketbeat.com - March 21 at 8:01 AMPiper Sandler Keeps Their Buy Rating on Tempest Therapeutics (TPST)markets.businessinsider.com - March 21 at 6:39 AMTempest Therapeutics: Tempest Reports Year End 2023 Financial Results and Provides Business Updatefinanznachrichten.de - March 20 at 3:37 PMWilliam Blair Reiterates "Outperform" Rating for Tempest Therapeutics (NASDAQ:TPST)marketbeat.com - March 20 at 11:19 AMTPST Stock Earnings: Tempest Therapeutics Beats EPS for Q4 2023investorplace.com - March 19 at 11:07 PMTempest Reports Year End 2023 Financial Results and Provides Business Updatefinance.yahoo.com - March 19 at 8:50 PMTempest Reports Year End 2023 Financial Results and Provides Business Updateglobenewswire.com - March 19 at 4:25 PMTempest Therapeutics, Inc. (NASDAQ:TPST) Short Interest Down 17.7% in Februarymarketbeat.com - March 15 at 11:20 AMGlancy Prongay & Murray LLP Announces Investigation of Tempest Therapeutics, Inc. (TPST)businesswire.com - March 14 at 3:56 PMTempest Therapeutics (NASDAQ:TPST) Research Coverage Started at Scotiabankmarketbeat.com - March 14 at 8:38 AMBuy Rating Affirmed for Tempest Therapeutics Amid Strong TPST-1120 Preclinical and Financial Prospectsmarkets.businessinsider.com - March 12 at 8:31 PMTempest Presents New Data at the SITC 2024 Spring Scientific Meeting Supporting Potent Anti-tumor Activity of TPST-1120 in Multiple Cancer Typesfinance.yahoo.com - March 12 at 10:29 AMTempest Therapeutics (NASDAQ:TPST) Shares Down 4.9% marketbeat.com - March 8 at 2:17 AMTempest Announces Upcoming Presentation of Preclinical Data for TPST-1120 in Renal Cell Carcinoma at the AACR Annual Meetingglobenewswire.com - March 5 at 4:30 PMTempest to Present at the 44th Annual TD Cowen Healthcare Conferencefinance.yahoo.com - February 26 at 2:06 PMTempest Therapeutics (NASDAQ:TPST) Receives New Coverage from Analysts at Jefferies Financial Groupmarketbeat.com - February 8 at 7:20 AMTempest Therapeutics (NASDAQ:TPST) Shares Down 0.7% marketbeat.com - February 3 at 12:38 AMTempest Therapeutics, Inc. (TPST)finance.yahoo.com - January 30 at 12:57 PMTempest Therapeutics Stock (NASDAQ:TPST), Short Interest Reportbenzinga.com - December 28 at 12:21 AMTempest Therapeutics Stock (NASDAQ:TPST) Insider Tradesbenzinga.com - December 11 at 8:37 AMTempest Therapeutics: Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)finanznachrichten.de - December 2 at 1:56 PMTempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)finance.yahoo.com - December 1 at 6:42 PMTempest to Present at the 35th Annual Piper Sandler Healthcare Conferencefinance.yahoo.com - November 20 at 9:19 AMGrowth Potential and Strategic Partnerships: Reasons for Aydin Huseynov’s Buy Rating on Tempest Therapeuticsmarkets.businessinsider.com - November 11 at 10:25 AMTempest Therapeutics (NASDAQ:TPST) Blasts Up on Improved Cash Picturemsn.com - November 11 at 10:25 AMAnalysts Offer Insights on Healthcare Companies: Amphastar Pharmaceuticals (AMPH), Atara Biotherapeutics (ATRA) and Tempest Therapeutics (TPST)markets.businessinsider.com - November 10 at 1:25 AMStrong 3Q23 Results and Promising Clinical Developments Reinforce Buy Rating for Tempest Therapeuticsmarkets.businessinsider.com - November 10 at 1:25 AMTempest Therapeutics stock rallies in wake of business updatemsn.com - November 9 at 3:25 PMTempest Reports Third Quarter 2023 Financial Results and Provides Business Updatefinance.yahoo.com - November 8 at 6:41 PMTempest Therapeutics (TPST) Price Target Increased by 38.30% to 22.10msn.com - November 1 at 7:44 PMMarketBeat Week in Review – 10/16 - 10/20 (TPST)marketbeat.com - October 21 at 7:00 AMWhat's Going On With Tempest Therapeutics Stock Today?benzinga.com - October 17 at 10:17 PMNavigating the Roller Coaster of Recent Penny Stock Surges (TPST)marketbeat.com - October 17 at 1:52 PMTempest Therapeutics continues wild ride as stock rallies 85% (update)msn.com - October 17 at 12:15 PMmarketbeat.com - October 17 at 9:44 AMThe Secrets Behind a 4000% Biotech Stock Surgemarketbeat.com - October 17 at 8:05 AMTempest Therapeutics continues wild ride as stock rallies 80%msn.com - October 16 at 12:53 PMmarketbeat.com - October 16 at 11:25 AMmarketbeat.com - October 16 at 10:59 AMTempest Therapeutics stock soars 4,000% on updated data (update)seekingalpha.com - October 14 at 6:27 PMTempest Therapeutics shares end wild week with 8% dropmsn.com - October 13 at 8:51 PM Get Tempest Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TPST and its competitors with MarketBeat's FREE daily newsletter. Email Address These AI trades triggered this morning (545% return) (Ad)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy TPST Media Mentions By Week TPST Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TPST News Sentiment▼0.000.37▲Average Medical News Sentiment TPST News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TPST Articles This Week▼02▲TPST Articles Average Week Get Tempest Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TPST and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: MNOV News ASRT News DERM News ANEB News CUE News LPTX News SLS News CRVS News IFRX News CARM News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TPST) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tempest Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
